Motaz Selim
( out of 40 reviews )

Motaz Selim, MBBCh, MD, PhD, MSc

Languages spoken: English

Clinical Locations

Primary Location

Primary Children's Hospital

Pediatric Surgery
100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-662-2950
Get Directions

University of Utah Hospital

General Surgery, Area E
50 N Medical Dr
Salt Lake City , UT 84132
801-585-1618
Get Directions

Motaz Selim, MBBCh, MSc, MD, PhD, is a transplant and hepatobiliary surgeon specializing in liver, kidney, and pancreas transplantation and surgical critical care. His interests include clinical outcomes in solid organ abdominal transplant, critical care of the pre- and post-transplant patients, mitigating preservation and reperfusion injury, and surgical education methods.

Dr. Selim received his MBBCh degree from Cairo University School of Medicine where he also finished his residency and received his Master and Doctorate degrees. He completed fellowship training in Transplant and Hepatobiliary Surgery at the Mount Sinai Medical Center New York, NY. He has published over 20 peer reviewed publications and presented in multiple national and international conferences.

He currently serves as an associate professor of surgery in the Department of Surgery, Division of Transplant & Advanced Hepatobiliary Surgery at University of Utah Health.

Dr. Selim's goal is to help end-stage organ failure patients safely receive a life-saving organ transplant and keep it functioning for as long as possible. His research goals align with his clinical goals to provide more access to transplant to more vulnerable and disadvantaged patients. He also aims to increase access to transplant for every patient by finding new and innovative techniques and methods to safely utilize more organs for transplantation.

In his spare time, Dr. Selim enjoys outdoor activities including biking, hiking, and kayaking. He is also an avid world traveler and photographer and is always looking for new places and cultures to learn about.

Specialties

Board Certification

Egyptian Medical Syndicate and Ministry of Health

Patient Rating

Patients consistently praise the physician for clear, thorough explanations of procedures and aftercare, and for taking time to answer questions. Reviewers describe him as personable, attentive, and caring, which helps put them at ease and inspires confidence in his clinical competence. Many note his communication style is direct but warm, and that he listens to concerns before outlining next steps.

Generated via Patient Reviews

4.8 /5
( out of 40 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

Mar 25, 2026
UNIVERSITY HOSPITAL

He was very thorough and honest while being cautiously optimistic.

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Motaz Selim, MBBCh, MSc, MD, PhD, is a transplant and hepatobiliary surgeon specializing in liver, kidney, and pancreas transplantation and surgical critical care. His interests include clinical outcomes in solid organ abdominal transplant, critical care of the pre- and post-transplant patients, mitigating preservation and reperfusion injury, and surgical education methods.

Dr. Selim received his MBBCh degree from Cairo University School of Medicine where he also finished his residency and received his Master and Doctorate degrees. He completed fellowship training in Transplant and Hepatobiliary Surgery at the Mount Sinai Medical Center New York, NY. He has published over 20 peer reviewed publications and presented in multiple national and international conferences.

He currently serves as an associate professor of surgery in the Department of Surgery, Division of Transplant & Advanced Hepatobiliary Surgery at University of Utah Health.

Dr. Selim's goal is to help end-stage organ failure patients safely receive a life-saving organ transplant and keep it functioning for as long as possible. His research goals align with his clinical goals to provide more access to transplant to more vulnerable and disadvantaged patients. He also aims to increase access to transplant for every patient by finding new and innovative techniques and methods to safely utilize more organs for transplantation.

In his spare time, Dr. Selim enjoys outdoor activities including biking, hiking, and kayaking. He is also an avid world traveler and photographer and is always looking for new places and cultures to learn about.

Board Certification and Academic Information

Academic Departments Surgery -Associate Professor (Clinical)
Academic Divisions Transplant & Advanced Hepatobiliary Surgery
Board Certification
Egyptian Medical Syndicate and Ministry of Health

Education history

Fellowship Surgical Education Leadership - Association for Surgical Education Fellow
Fellowship Surgical Critical Care - Medical College of Wisconsin Fellow
Fellowship Abdominal Organ Transplant Surgery - Medical College of Wisconsin Fellow
Fellowship Abdominal Organ Transplant Surgery - Recanati/Miller Transplantation Institute, Mount Sinai Medical Center Fellow
Professional Medical Medicine - Faculty of Medicine Kasr Al-Ainy, Cairo University M.D., Ph.D.
Fellowship Vascular Surgery - Texas Heart Institute Fellow
Graduate Training Faculty of Medicine Kasr Al-Ainy, Cairo University M.Sc.
Residency General Surgery - Faculty of Medicine Kasr Al-Ainy, Cairo University Resident
Internship Faculty of Medicine Kasr Al-Ainy, Cairo University Intern
Undergraduate Medicine & Surgery - Faculty of Medicine Kasr Al-Ainy, Cairo University M.B.B.Ch.

Selected Publications

Journal Article

  1. Yamauchi J, Fornadi K, Raghavan D, Jweehan D, Oygen S, Marineci S, Buff M, Fenlon M, Selim M, Zimmerman M, Molnar MZ (2025). Development of BK polyomavirus-associated nephropathy risk prediction in kidney transplant recipients. Ren Fail, 47(1), 2509785.
  2. Nwaduru C, Olsen A, Ovalle LA, Selim M, Buff M, Fenlon M, Zimmerman MA (2025). Challenging the Distance-Morbidity Paradigm Following Liver Transplantation: A Single Center Experience. J Surg Res, 315, 829-838.
  3. Yamauchi J, Cizik AM, Fornadi K, Thomas D, Raghavan D, Jweehan D, Oygen S, Marineci S, Buff M, Selim M, Zimmerman M, Mucsi I, Molnar MZ (2025). Associations of Pretransplant Patient-Reported Outcomes Measurement Information System Physical Function Score With Kidney Transplant Outcomes. Transpl Int, 38, 13884.
  4. Nwaduru C, Baker E, Buff M, Selim M, Ovalle LA, Baker TB, Zimmerman MA (2024). Assessing Liver Viability: Insights From Mitochondrial Bioenergetics in Ischemia-Reperfusion Injury. Transplant Proc, 56(1), 228-235.
  5. Durazo FA, Kristbaum K, Miller J, Saeian K, Selim M, Hong JC (2022). De Novo Autoimmune Hepatitis after COVID-19 Infection in an Unvaccinated Patient. Case Reports Hepatol, 2022, 8409269.
  6. Mahaffey JJ, Selim MA, Kristbaum KA, Mayer J, Martin A, Durazo FA, Hong JC (2022). Evolution of a Transplant Surgery Advanced Practice Provider Practice Model in the Care of High-Acuity Liver Transplant Recipients: A Single-Center Experience. Transplant Proc, 54(10), 2621-2626.
  7. Zanowski SC, Price JS, Selim MA, Schumann V, Durazo F, Hong JC (2022). Effect of an Integrated Transplantation Mental Health Program on Alcohol Relapse After Liver Transplantation for Severe Alcoholic Hepatitis: A Single-Center Prospective Study. Transplant Proc, 54(10), 2627-2633.
  8. Mayer J, Selim MA, Mahaffey JJ, Martin A, Hong JC (2022). Assessment of Patient Knowledge of the Role of Advanced Practice Providers in Transplantation Surgical Care: A Single-Center Prospective Study. Transplant Proc, 54(10), 2616-2620.
  9. Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC (2020). Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation. J Surg Res, 255, 99-105.
  10. Pearson T, Zimmerman MA, Kim J, Palines PA, Eriksen CM, Wong M, Selim MA, Markovic D, Hong JC (2019). Staged Biliary Reconstruction After Orthotopic Liver Transplantation: A Practical Surgical Strategy for High-Acuity Adult Recipients. Transplant Direct, 5(9), e482.
  11. Zimmerman MA, Selim M, Kim J, Saeian K, Cinquegrani MP, Connolly L, Woehlck HJ, Lauer KK, Hong JC (2018). Impact of a Transplantation Critical Care Model on Short-Term Outcomes Following Liver Transplantation in High Acuity Patients: A Single-Center Experience. Transplant Proc, 50(10), 3544-3548.
  12. Zimmerman MA, Selim M, Kim J, Kozeniecki M, Hong JC (2018). A Specialized Transplantation Critical Care Model: Expanding Liver Transplantation Access to High-Acuity Patients. Transplant Proc, 50(9), 2619-2621.
  13. Zimmerman MA, Selim M, Kim J, Regner K, Saeian K, Zanowski S, Martin A, Connolly LA, Lauer KK, Woehlck HJ, Hong JC (2016). Outcome analysis of continuous intraoperative renal replacement therapy in the highest acuity liver transplant recipients: A single-center experience. Surgery, 161(5), 1279-1286.
  14. Woehlck HJ, Boettcher BT, Lauer KK, Cronin DC, Hong JC, Zimmerman MA, Kim J, Selim M (2016). Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm. A A Case Rep, 7(12), 247-250.
  15. Zimmerman MA, Schiller J, Kim J, Martin A, Selim M, Nydam TL, Cronin D 2nd, Hong JC (2015). Pathologic sequelae of allosensitization in liver transplantation. J Surg Res, 200(1), 195-9.
  16. Facciuto ME, Singh MK, Lubezky N, Selim MA, Robinson D, Kim-Schluger L, Florman S, Ward SC, Thung SN, Fiel M, Schiano TD (2014). Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation, 99(1), 151-7.
  17. Selim M, Goldstein MJ (2011). Case report: parenchymal pseudoaneurysm of a renal allograft after core needle biopsy: a rare cause of allograft injury. Transplant Proc, 43(7), 2781-3.

Review

  1. Nwaduru C, Anyagwa OE, Fenlon M, Buff M, Selim M, Botha J, Kastenberg Z, Zimmerman M (2026). Purinergic signaling and cholangiocyte regeneration: a new frontier in ischemic liver injury. [Review]. Front Transplant, 4, 1731982.
  2. Nwaduru C, Ovalle LA, Hoareau GL, Baker E, Buff M, Selim M, Baker TB, Zimmerman MA (2024). Ectonucleotidases in Ischemia Reperfusion Injury: Unravelling the Interplay With Mitochondrial Dysfunction in Liver Transplantation. [Review]. Transplant Proc, 56(7), 1598-1606.
  3. Andacoglu OM, Wiser G, Zimmerman M, Buff M, Selim M, Baker T (2024). A perspective and review on nondirected liver donation. [Review]. Clin Liver Dis (Hoboken), 23(1), e0235.
  4. Nath S, Koziarz A, Badhiwala JH, Alhazzani W, Jaeschke R, Sharma S, Banfield L, Shoamanesh A, Singh S, Nassiri F, Oczkowski W, Belley-Ct E, Truant R, Reddy K, Meade MO, Farrokhyar F, Bala MM, Alshamsi F, Krag M, Etxeandia-Ikobaltzeta I, Kunz R, Nishida O, Matouk C, Selim M, Rhodes A, Hawryluk G, Almenawer SA (2017). Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. [Review]. Lancet, 391(10126), 1197-1204.

News & Podcasts

Podcasts